Malaria as a Protection Factor Against Severe COVID-19 (Known as SARS-COV-2) in the Democratic Republic of Congo (Palu-COVID)

NCT05012280 · clinicaltrials.gov ↗
TERMINATED
Status
238
Enrollment
OTHER
Sponsor class

Stopped As the COVID-19 epidemic evolved, presentation of the disease changed substantially. Due to vaccination, increased natural immunity and new variants, there is a substantial decrease in severe cases, making it difficult to recruit new patients.

Conditions

Sponsor

Institute of Tropical Medicine, Belgium